Document is current
Any future updates will be listed below
-
Authors
Herrmann, Job J. https://orcid.org/0000-0001-5923-3720
Brunner-La Rocca, Hans-Peter
Baltussen, Lisette E. H. J. M.
Beckers-Wesche, Fabienne
Bekkers, Sebastiaan C. A. M.
Bellersen, Louise
van Eck, J. W. Martijn
Hassing, H. Carlijne
Jaarsma, Tiny
Linssen, Gerard C. M. https://orcid.org/0000-0002-3339-1955
Pisters, Ron
Sanders-van Wijk, Sandra
Verdijk, Marjolein H. I.
Handoko, M. Louis https://orcid.org/0000-0002-8942-7865
van der Meer, Peter https://orcid.org/0000-0002-9705-4413
Verbrugge, Frederik H. https://orcid.org/0000-0003-0599-9290
Januzzi, James L. Jr
Bayés-Genís, Antoni
Nieuwlaat, Robby
Rodwell, Laura
Gommans, D. H. Frank
van Kimmenade, Roland R. J. https://orcid.org/0000-0002-8207-8906
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 4 March 2025
First Online: 30 March 2025
Competing interests
: H.-P.B.-L.R. has received research grants from Innovative Health Initiative Joint Undertaking and Roche Diagnostics, received consulting fees from Astra Zeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics and Vifor Pharma, received honoraria from Roche Diagnostics and participated on an Advisory Board of CeleCor Therapeutics. S.S.-v.W. has received research grants from Boehringer Ingelheim, CRL funds and ZonMW, received honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Roche Diagnostics and Pfizer, and is a member of the board of the Werkgroep Cardiologisch Centra Nederland and Stichting Perfusie. P.v.d.M. has received research grants from Astra Zeneca, Pfizer, Pharma Nord, Novo Nordisk, Ionis and Vifor Pharma, honoraria from Astra Zeneca, Boehringer Ingelheim, BridgeBio, Daiichi Sankyo, Ionis, Novartis, Novo Nordisk, Pfizer, Pharma Nord, Pharmacosmos and Vifor Pharma, and participated on an Advisory Board for CorHeart. J.L.J. has received research grants from Abbott, Applied Therapeutics, Astra Zeneca, HeartFlow and Novartis, received consulting fees from Abbott, Applied Therapeutics, Astra Zeneca, Beckman, Boehringer Ingelheim, Bristol Myers, Intellia, Jana Care, Novartis, Pfizer, Merck, Roche Diagnostics and Siemens, participated on an Advisory Board for Abbott, AbbVie, Bayer, CVRx, Roche Diagnostics and Takeda, is a member of the board of American College of Cardiology and Imbria Pharmaceuticals, and has stock (options) in Imbria Pharmaceuticals and Jana Care. A.B.-G. has lectured and/or participated in advisory boards for Abbott, Astra Zeneca, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Novo Nordisk, Roche Diagnostics and Vifor Pharma. D.H.F.G. received a speaker’s fee from Novartis and travel support from Astra Zeneca. R.R.J.v.K. received consulting fees from Novo Nordisk and Roche Diagnostics, honoraria from Hippocrates Academy and is a fiduciary member of the ESC working group on Peripheral Artery and Aortic Disease. The other authors declare no competing interests.
